

Cover Story
COVID-19 & CancerFreeGuest Editorial
The past two decades have brought hope to myeloma patients, as the majority benefit from the significant advances in chemotherapy.
Free
By Matthew Bin Han Ong
In Brief
Clinical Roundup


Drugs & Targets


Trending Stories
- Anthony G. Letai to be named NCI director
The Dana-Farber and Harvard physician-scientist is an inspired choice, colleagues say - NCI releases names of members of ad hoc working group—filling the void left by BSA
- Trump’s FDA invents an unusual regulatory pathway to approve leucovorin for autism
Experts call the move “extremely premature” - ACOG says it will no longer accept federal funding
- Bhattacharya: New grant review criterion is “not political”
- Jonathan Mahler on his front-page story in the NYT Magazine on Trump’s deliberate dismantling of America’s War on Cancer